Suchergebnisse - "Fahad S. Alshehri"

PubPharm (19)

1

Protective role of resveratrol against VCM-induced hepatotoxicity in male wistar rats

in: Frontiers in Pharmacology | 2023

von Fahad S. Alshehri | Nasser M. Alorfi

2

Resveratrol Ameliorates Vancomycin-Induced Testicular Dysfunction in Male Rats

in: Medicina | 2023

von Fahad S. Alshehri

3

Amphetamines in child medicine: a review of ClinicalTrials.gov

in: Frontiers in Pharmacology | 2023

von Samer O. Alalalmeh | Samer O. Alalalmeh | Omar E. Hegazi | +7

4

A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov

in: Medicina | 2023

von Fahad S. Alshehri

5

Evaluation of Pharmacology and Pathophysiology Knowledge of Epilepsy among Senior Pharmacy Students: A Single Center Experience

in: Medicina | 2023

von Nasser M. Alorfi | Ahmed M. Ashour | Hanouf S. Bafhaid | +1

6

Psychological Distress During COVID-19 Curfews and Social Distancing in Saudi Arabia: A Cross-Sectional Study

in: Frontiers in Public Health | 2022

von Badrah S. Alghamdi | Badrah S. Alghamdi | Yasser Alatawi | +4

7

Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model

in: Biomedicine & Pharmacotherapy | 2022

von Usman Sabir | Hafiz Muhammad Irfan | Alamgeer | +4

8

Deciphering the Link Between ERUPR Signaling and MicroRNA in Pathogenesis of Alzheimer’s Disease

in: Frontiers in Aging Neuroscience | 2022

von Nusrath Yasmeen | Manali Datta | Vikram Kumar | +5

9

Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials

in: Saudi Pharmaceutical Journal | 2022

von Abdullah A. Alhifany | Nisrin Bifari | Yasser Alatawi | +8

10

PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases

in: Pharmaceutics | 2022

von Hashem O. Alsaab | Fatima D. Alharbi | Alanoud S. Alhibs | +8